Celcuity Inc. (CELC)
NASDAQ · Healthcare
$87.99-0.44%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $5.64B
- P/E ratio
- —
- EPS
- —
- Volume
- 981,232
- 52-week high
- —
- 52-week low
- —
- Open
- $88.56
- Day high
- $92.10
- Day low
- $87.87
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | — | -$177.04M | -$3.79 |
| 2024 | — | -$111.78M | -$2.83 |
| 2023 | — | -$63.78M | -$2.69 |
| 2022 | — | -$40.37M | -$2.64 |
| 2021 | — | -$29.61M | -$2.21 |
About Celcuity Inc.
Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.
- CEO
- Brian F. Sullivan
- Employees
- 155
- Country
- US
- IPO date
- Sep 19, 2017
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Celcuity Inc.'s stock price today?
- CELC is trading at $87.99 as of Jul 20, 2026.
- What is Celcuity Inc.'s market cap?
- Celcuity Inc. (CELC) has a market capitalization of $5.64B.
- Does Celcuity Inc. pay a dividend?
- Celcuity Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is Celcuity Inc. in?
- Celcuity Inc. operates in the Healthcare sector.